Cardiac Ablation Technologies Market Size Will Attain USD 12.6 Billion by 2030 growing at 11.6% CAGR - Exclusive Report by Acumen Research and Consulting

LOS ANGELES , Nov. 28, 2022 (GLOBE NEWSWIRE) -- The Global Cardiac Ablation Technologies Market Size accounted for USD 4.8 Billion in 2021 and is projected to occupy a market size of USD 12.6 Billion by 2030 growing at a CAGR of 11.6% from 2022 to 2030.

Cardiac Ablation Technologies Market Statistics

• Global cardiac ablation technologies market value was USD 4.8 Billion in 2021 and expected to grow at CAGR of 11.6% from 2022 to 2030
• North America cardiac ablation technologies market revenue accounts around 41% share in 2021
• According to the CDC, 697,000 people died from heart disease in the United States in 2020
• Asia-Pacific cardiac ablation technologies market growth will register considerable CAGR of over 12% from 2022 to 2030
• Among technology type, radiofrequency gathered USD 2.6 billion revenue in 2021
• Based on end-use, energy-based technology occupied approximately USD 3 billion revenue in 2021
• Rising technological advancements in these technologies is a global cardiac ablation technologies market trend driving the industry demand
  
  

Cardiac Ablation Technologies Market Growth Factors

• Growing incidences of cardiac arrhythmias
• Rising geriatric people across the world
• Growing trend for minimally invasive procedures
  

Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/1190

Cardiac Ablation Technologies Market Report Coverage:

Cardiac Ablation Technologies Market Dynamics

The growing elderly population in developed countries is expected to propel the global cardiac ablation technologies market forward.

There are several factors driving the growth of the global cardiac ablation technologies market, including an increase in cardiovascular disease patients, an ageing population, technological breakthroughs in the field of ablation devices, and rising awareness about the numerous advantages of cardiac ablation procedures over conventional procedures. However, stringent measures implemented by several governments, as well as ongoing healthcare reforms in the United States, are major factors that may have a negative impact on the expansion of the cardiac ablation technologies market. Untapped growth opportunities exist in emerging countries such as China, Mexico, and India for players involved in the manufacturing and consumption of cardiac ablation products. A variety of factors, including increasing ablation adoption in disease treatment and rising market penetration of product manufacturers across numerous developing countries, are providing opportunities for growth for key participants in the cardiac ablation technologies market.

Increased awareness of minimally invasive procedures leads to increased adoption because there is less pain and scarring, and it is also less expensive than traditional surgeries. Tissue removal involves a variety of ablation techniques. In the treatment of numerous prostate, lung, and liver tumours, minimally invasive surgeries are emerging as a possible substitute for conventional therapeutic surgeries. Furthermore, the use of advanced robotic technologies in the cardiac ablation process is safer and more accurate. As a result, the advancement of technology in ablation devices is anticipated to create growth opportunities for the cardiac ablation technologies market in the coming years.

Check the detailed table of contents of the report @

https://www.acumenresearchandconsulting.com/table-of-content/cardiac-ablation-technologies-market

Cardiac Ablation Technologies Market Segmentation

The global market for cardiac ablation technologies is divided into four segments: technology type, application, end-user, and region. The global cardiac ablation technologies market is divided into cryoablation, radiofrequency, laser, microwave, ultrasound, and others based on technology type. The global cardiac ablation technologies market is divided into three applications: atrial fibrillation, ventricular tachycardia, and ophthalmic applications. End-user segment comprises hospitals, ambulatory surgical centers, and cardiac centers. Furthermore, the global cardiac ablation technologies market is divided into five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Cardiac Ablation Technologies Market Share

The radiofrequency segment accounted for approximately 56% of the global market in terms of technology type. Atrial fibrillation is expected to have a significant market share between 2022 and 2030, according to the cardiac ablation technologies market forecast. As per the global cardiac ablation technologies industry analysis, hospitals accounted for a sizable portion of total end-user shares in 2021 and are expected to grow significantly over the forecast period.

Cardiac Ablation Technologies Market Regional Growth

North America and Europe held the lion's share of the global cardiac ablation technologies market, followed by Asia-Pacific and Latin America. The presence of a large geriatric population, as well as the high prevalence of several heart rhythm conditions such as atrial fibrillation (AF), tachycardia, and atrial flutter, fueled demand for cardiac ablation technologies in these regions. The Asia-Pacific cardiac ablation technologies market is expected to grow at a faster CAGR during the forecast period. The region's market is expected to be fueled in the coming years by an increase in health awareness and health care expenditure. Furthermore, low-cost manufacturing in developing countries is spurring growth in the Asia-Pacific region.

Buy this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/1190

Cardiac Ablation Technologies Market Players

The key players catering to the global cardiac ablation technologies market are Advanced Cardiac Therapeutics, Alcon Laboratories Inc., Biosense Webster, Inc. (Johnson & Johnson), Boston Scientific Corporation, CardioFocus Inc., CONMED Corporation, Medtronic Plc, MicroPort Scientific Corporation, Olympus Corporation, St. Jude Medical, Inc. (Abbott), and Stryker Corporation. These companies have established their prominent position in the global market and has huge customer base. These companies have established a strong presence in the global market and have a large customer base. They have a diverse product offering and a global distribution system for cardiac ablation products. Furthermore, the entry of small businesses, particularly in Asia Pacific's developing markets, is being observed. Strict government regulations and high-quality standards set by market leaders, on the other hand, are expected to limit the growth of new players in the global cardiac ablation technologies market. Partnerships, new product launches, acquisitions, and mergers are all important strategic initiatives undertaken by global corporations. Increasing R&D investments, along with technological advancements to commercialize highly efficient ablation products, are expected to provide lucrative opportunities for industry players in the global cardiac ablation technologies market.

Questions Answered By This Report

• What was the market size of Cardiac Ablation Technologies Market in 2021?
• What will be the CAGR of Cardiac Ablation Technologies Market during the forecast period from 2022 to 2030?
• Who are the major players in Global Cardiac Ablation Technologies Market?
• Which region held the largest share in Cardiac Ablation Technologies Market in 2021?
• What are the key market drivers of Cardiac Ablation Technologies Market?
• Who is the largest end user Cardiac Ablation Technologies Market?
• What will be the Cardiac Ablation Technologies Market value in 2030?
  

Browse More Research Topic on Healthcare Sector Related:

Cardiac Arrhythmia Monitoring Devices Market size accounted for USD 6,485 Million in 2021 and is expected to reach USD 11,490 Million by 2030 with a considerable CAGR of 6.8% during the forecast timeframe of 2022 to 2030.

Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of around 7.5% from 2020 to 2027 and expected to reach the market value of around USD 25.5 Billion by 2027.

The Global Cardiology Market is expected to grow at a CAGR of around 8.8% from 2020 to 2027 and projected to reach the market value of around USD 24.3 Billion by 2027.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

For Latest Update Follow Us on Twitter , Instagram and LinkedIn

Contact Us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com